Also trades as: 0GZV.IL (IOB) · $vol 3M · GNGBY (OTC) · $vol 0M · GNGBF (OTC) · $vol 0M

kr 246.40 ($24.54)

-0.80 (-0.32%)

Weekly Expected Move ±2.9%

kr 232 kr 239 kr 246 kr 254 kr 261

STO · Healthcare · Medical - Devices · Tech Score Buy · Power 61 · kr 67.1B mcap · 215M float · 0.253% daily turnover

Revenue

$35.0B +0.6% ▲

5Y CAGR: +3.2%

Gross Profit

$15.5B -3.8% ▼

5Y CAGR: +1.1%

Operating Income

$4.6B +60.0% ▲

5Y CAGR: -0.9%

Net Income

$2.3B +37.9% ▲

5Y CAGR: -7.0%

EPS (Diluted)

$8.29 +37.9% ▲

5Y CAGR: -7.0%

EBITDA

$5.9B +10.2% ▲

5Y CAGR: -2.0%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$27.0B	$28.3B	$31.8B	$34.8B	$35.0B
YoY Growth	-9.3%	+4.6%	+12.5%	+9.2%	+0.6%
Cost of Revenue	$13.5B	$14.9B	$17.3B	$18.6B	$19.4B
Gross Profit	$13.6B	$13.4B	$14.5B	$16.2B	$15.5B
Gross Margin	50.2%	47.4%	45.5%	46.5%	44.5%
R&D Expenses	$851M	$1.2B	$985M	$1.4B	$1.5B
SG&A Expenses	$7.9B	$8.4B	$9.7B	$9.6B	$9.5B
Operating Expenses	$9.3B	$9.5B	$10.8B	$13.3B	$11.0B
Operating Income	$4.4B	$3.6B	$3.7B	$2.9B	$4.6B
Operating Margin	16.2%	12.8%	11.7%	8.2%	13.1%
Interest Expense	$193M	$228M	$493M	$606M	$644M
Income Before Tax	$4.2B	$3.5B	$3.3B	$2.3B	$3.1B
Tax Expense	$1.2B	$956M	$915M	$628M	$869M
Net Income	$3.0B	$2.5B	$2.4B	$1.6B	$2.3B
Net Margin	11.0%	8.8%	7.6%	4.7%	6.5%
EPS (Diluted)	$10.90	$9.15	$8.86	$6.01	$8.29
EBITDA	$6.2B	$5.7B	$5.9B	$5.3B	$5.9B
Shares Outstanding	272M	272M	272M	272M	272M

Line Item	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2
Revenue	$7.9B	$11.1B	$8.3B	$8.2B	$8.2B	$10.2B	$7.4B	$8.4B
Cost of Revenue	$4.3B	$6.0B	$4.2B	$4.3B	$4.7B	$5.7B	$3.8B	$4.0B
Gross Profit	$3.6B	$5.1B	$4.1B	$3.9B	$3.5B	$4.5B	$3.6B	$4.4B
Gross Margin	45.2%	45.6%	49.2%	47.8%	43.0%	44.1%	48.4%	52.7%
R&D Expenses	$319M	$446M	$318M	$343M	$286M	$485M	$328M	$358M
SG&A Expenses	$2.5B	$3.0B	$2.8B	$2.6B	$2.2B	$2.4B	$2.3B	$2.7B
Operating Expenses	$3.4B	$4.0B	$3.5B	$3.1B	$2.5B	$2.9B	$2.9B	$3.1B
Operating Income	$184M	$1.1B	$598M	$867M	$1.0B	$1.6B	$726M	$1.4B
Operating Margin	2.3%	9.8%	7.2%	10.5%	12.2%	15.3%	9.8%	16.1%
Interest Expense	$152M	$173M	$170M	$147M	$163M	$164M	$135M	$133M
Income Before Tax	$32M	$911M	$428M	$721M	$789M	$1.2B	$573M	$1.2B
Tax Expense	$23M	$243M	$124M	$194M	$214M	$338M	$170M	$312M
Net Income	$2M	$664M	$300M	$524M	$566M	$868M	$401M	$841M
Net Margin	0.0%	6.0%	3.6%	6.4%	6.9%	8.5%	5.4%	10.0%
EPS (Diluted)	$0.01	$2.44	$1.10	$1.92	$2.08	$3.19	$1.47	$3.09
EBITDA	$861M	$2.6B	$1.5B	$1.4B	$1.5B	$1.9B	$1.2B	$1.9B
Shares Outstanding	272M	272M	272M	272M	272M	272M	272M	272M

GETI-B.ST STO